YU47943B - Etri 1-benzil-3-hidroksimetil-indazola sa alifatičnim 2-hidroksi kiselinama i postupak dobijanja - Google Patents

Etri 1-benzil-3-hidroksimetil-indazola sa alifatičnim 2-hidroksi kiselinama i postupak dobijanja

Info

Publication number
YU47943B
YU47943B YU20690A YU20690A YU47943B YU 47943 B YU47943 B YU 47943B YU 20690 A YU20690 A YU 20690A YU 20690 A YU20690 A YU 20690A YU 47943 B YU47943 B YU 47943B
Authority
YU
Yugoslavia
Prior art keywords
benzyl
indazole
hydroxymethyl
hydroxy acids
aliphatic
Prior art date
Application number
YU20690A
Other languages
English (en)
Other versions
YU20690A (sh
Inventor
B. Sil Vestrini
L. Baiocchi
Original Assignee
Aziende Chemiche Riunite Agelini Francesco A.C.R.A.F. S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chemiche Riunite Agelini Francesco A.C.R.A.F. S.P.A. filed Critical Aziende Chemiche Riunite Agelini Francesco A.C.R.A.F. S.P.A.
Priority to SI9010206A priority Critical patent/SI9010206A/sl
Publication of YU20690A publication Critical patent/YU20690A/sh
Priority to HRP-206/90A priority patent/HRP940878B1/xx
Publication of YU47943B publication Critical patent/YU47943B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

ETRI 1-BENZIL-3-HIDROKSIMETIL-INDAZOLA SA ALIFATIČNIM 2-HIDROKSI KISELINAMA I POSTUPAK DOBIJANJA, jedinjenje, naznačeno time, što ima formulu: A-CH2-O-CRR'-COOR"' (I) u kojoj A predstavlja 1-benzil-indazol-3-il jezgro; R i R' mogu da budu isti ili različiti i predstvljaju vodonik ili C1-5 alkil; R"' je vodonik ili ostatak alifatičnog zasićenog alkohola koji ima od 1 do 4 ugljenikova atoma; i, kada R"' predstavlja vodonik, njihove soli sa farmaceutski prihvatljivim bazama. Prijava sadrži još 2 nezavisna i 13 zavisnih zahteva.
YU20690A 1989-02-07 1990-02-05 Etri 1-benzil-3-hidroksimetil-indazola sa alifatičnim 2-hidroksi kiselinama i postupak dobijanja YU47943B (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI9010206A SI9010206A (sl) 1989-02-07 1990-02-05 Etri 1-benzil-3-hidroksimetil-indazola z alifatskimi 2-hidroksi kislinami
HRP-206/90A HRP940878B1 (en) 1989-02-07 1994-10-28 Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (2)

Publication Number Publication Date
YU20690A YU20690A (sh) 1992-07-20
YU47943B true YU47943B (sh) 1996-07-24

Family

ID=11261479

Family Applications (1)

Application Number Title Priority Date Filing Date
YU20690A YU47943B (sh) 1989-02-07 1990-02-05 Etri 1-benzil-3-hidroksimetil-indazola sa alifatičnim 2-hidroksi kiselinama i postupak dobijanja

Country Status (36)

Country Link
US (2) US4999367A (sh)
EP (1) EP0382276B1 (sh)
JP (1) JP2870925B2 (sh)
KR (1) KR0145525B1 (sh)
CN (2) CN1046505C (sh)
AR (1) AR247386A1 (sh)
AT (1) ATE127115T1 (sh)
AU (1) AU624895B2 (sh)
BG (1) BG50273A3 (sh)
CA (1) CA2009503C (sh)
CZ (1) CZ280121B6 (sh)
DD (2) DD291995A5 (sh)
DE (2) DE382276T1 (sh)
DK (1) DK0382276T3 (sh)
EG (1) EG19170A (sh)
ES (1) ES2020171T3 (sh)
FI (1) FI102678B1 (sh)
GE (1) GEP19971030B (sh)
GR (2) GR910300073T1 (sh)
HU (1) HU204793B (sh)
IL (1) IL93132A (sh)
IN (1) IN170957B (sh)
IT (1) IT1230441B (sh)
LT (1) LT3604B (sh)
LV (1) LV10612B (sh)
NZ (1) NZ232258A (sh)
PE (1) PE25091A1 (sh)
PH (1) PH26552A (sh)
PL (2) PL163730B1 (sh)
PT (1) PT93067B (sh)
RO (1) RO106252B1 (sh)
RU (3) RU2066318C1 (sh)
SK (1) SK56390A3 (sh)
UA (1) UA26852C2 (sh)
YU (1) YU47943B (sh)
ZA (1) ZA90644B (sh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) * 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
AU2009221089B2 (en) 2008-03-07 2013-12-05 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
LT2262778T (lt) 2008-03-07 2019-11-11 Acraf 1-benzil-3-hidroksimetilindazolo dariniai ir jų panaudojimas gydant ligas, pagrįstas mcp-1, cxcr1 ir p40 raiška
KR101581829B1 (ko) 2008-03-07 2015-12-31 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 1-벤질-3-하이드록시메틸인다졸 유도체들 및 ｍｃｐ-1 및 ｃｘ3ｃｒ1의 발현을 기초로 한 질환들의 치료에서 이의 용도
CN106518769A (zh) 2009-08-03 2017-03-22 方济各安吉利克化学联合股份有限公司 1‑苄基‑3‑羟甲基‑1h‑吲唑及其衍生物以及所需镁中间体的制备方法
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
CA2911041C (en) 2012-05-01 2020-12-15 Shelley Romayne BOYD Methods for treating and diagnosing blinding eye diseases
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
EP2850062B1 (en) 2012-05-18 2017-07-19 Sanofi Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation
SG11201407210SA (en) 2012-05-18 2014-12-30 Sanofi Sa Pyrazole derivatives and their use as lpar5 antagonists
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
US11753382B2 (en) 2019-06-25 2023-09-12 Translatum Medicus Inc. Processes of making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
BG50273A3 (en) 1992-06-15
EP0382276B1 (en) 1995-08-30
LV10612A (lv) 1995-04-20
RU2044729C1 (ru) 1995-09-27
CN1034016C (zh) 1997-02-12
KR0145525B1 (ko) 1998-08-17
SK278441B6 (en) 1997-05-07
CA2009503A1 (en) 1990-08-07
DE69021902D1 (de) 1995-10-05
AU4906690A (en) 1990-08-16
FI102678B (fi) 1999-01-29
ATE127115T1 (de) 1995-09-15
AU624895B2 (en) 1992-06-25
US4999367A (en) 1991-03-12
EP0382276A2 (en) 1990-08-16
RO106252B1 (ro) 1993-03-31
IN170957B (sh) 1992-06-20
DK0382276T3 (da) 1996-01-15
HUT53088A (en) 1990-09-28
FI102678B1 (fi) 1999-01-29
GEP19971030B (en) 1997-06-13
CZ280121B6 (cs) 1995-11-15
PT93067B (pt) 1995-12-29
AR247386A1 (es) 1994-12-29
LT3604B (en) 1995-12-27
FI900577A0 (fi) 1990-02-06
UA26852C2 (uk) 1999-12-29
CA2009503C (en) 2000-04-11
LV10612B (en) 1995-08-20
ES2020171A4 (es) 1991-08-01
IL93132A (en) 1994-05-30
US5112986A (en) 1992-05-12
CN1088201A (zh) 1994-06-22
GR910300073T1 (en) 1991-11-15
SK56390A3 (en) 1997-05-07
ES2020171T3 (es) 1995-12-01
DD291995A5 (de) 1991-07-18
PE25091A1 (es) 1991-08-17
HU204793B (en) 1992-02-28
CN1044810A (zh) 1990-08-22
PH26552A (en) 1992-08-19
DD295363A5 (de) 1991-10-31
EP0382276A3 (en) 1990-12-12
CZ56390A3 (en) 1995-06-14
PL163720B1 (pl) 1994-04-29
IT8947620A0 (it) 1989-02-07
NZ232258A (en) 1991-06-25
DE69021902T2 (de) 1996-05-23
HU900689D0 (en) 1990-04-28
PL163730B1 (pl) 1994-04-29
JP2870925B2 (ja) 1999-03-17
RU2066318C1 (ru) 1996-09-10
RU2055071C1 (ru) 1996-02-27
ZA90644B (en) 1991-01-30
EG19170A (en) 1994-11-30
LTIP872A (en) 1995-03-27
KR900012913A (ko) 1990-09-03
IL93132A0 (en) 1990-11-05
PT93067A (pt) 1990-08-31
DE382276T1 (de) 1991-11-28
YU20690A (sh) 1992-07-20
IT1230441B (it) 1991-10-23
JPH02240065A (ja) 1990-09-25
GR3018165T3 (en) 1996-02-29
CN1046505C (zh) 1999-11-17

Similar Documents

Publication Publication Date Title
YU47943B (sh) Etri 1-benzil-3-hidroksimetil-indazola sa alifatičnim 2-hidroksi kiselinama i postupak dobijanja
MY131271A (en) Liquid detergents with an aryl boronic acid for inhibition of proteolytic enzyme
GB1423006A (en) Herbicidal compositions containing 4-phenoxy-phenoxy-propionic acid derivatives
CA2053253A1 (en) New aryl-and heteroarylethenylene derivatives and process for their preparation
RS49531B (sr) Estrogen agonisti/antagonisti
YU46414B (sh) Postupak za dobivanje hinolinskih derivata
YU47099B (sh) Postupak za dobijanje makrolidnih jedinjenja
ES8301925A1 (es) Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico
RS49586B (sr) Derivati supstituisane 4-hidroksi-fenilalkanske kiseline sa dejstvom agonista na ppar-gama
ES8605506A1 (es) Procedimiento para preparar derivados de piperidina
AU528275B2 (en) Imidazole derivatives
MY100095A (en) 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition.
EP1175208A4 (en) COMPOSITION FOR PREVENTION OR TREATMENT OF DEMENTIA CONTAINING A HYDROXYCINNAMIC ACID DERIVATIVE OR AN EXTRACT OF AN ANGELICAE SPECIES CONTAINING SAID ACID
ES8802421A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
ES2000779A6 (es) Un procedimiento para preparar derivados de piridazinona y metodo para reprimir plagas de insectos usando dichos derivados.
MY101261A (en) New 4-pyridone derivatives, method of their production and their pharmaceutical compositions.
ES454063A1 (es) Un procedimiento para la preparacion de nuevos derivados delalcohol bencilico.
SE8403268L (sv) 1,4-dihydropyridinderivat, deras framstellning och farmaceutiska beredningar innehallande dessa
ES8100283A1 (es) Un procedimiento para la preparacion de derivados del acido 4,5-dihidro-4-oxofuran-2-carboxilico
ES468658A1 (es) Un procedimiento para preparar 4-alcohiltio-2-trifluorome- tilalcanosulfonanilidas y sus derivados
RS49832B (sr) Postupak za dobijanje aminskih derivata alkiloksifuranona, dobijanje jedinjenja i upotreba ovih jedinjenja
GR861205B (en) Method for preparing hexenoic acids
YU46483B (sh) Postupak za dobijanje kondenzovanih derivata pirimidina
YU47508B (sh) Novi feniletanolamino derivati i postupak za njihovo dobijanje
JPS5772981A (en) 1,8-naphthyridine derivative and its salt